| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.094 | 0.6 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.15 | 0.6 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |